Atlas Trials

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Clinical trial NCT00004058 · TERMINATED

Trial details

NCT number
NCT00004058
Sponsor
University of Medicine and Dentistry of New Jersey
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesPrecancerous/Nonmalignant Condition
Start date
1998-12-01
Primary completion
2004-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.